Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 3 clinical trial of duloxetine in children and adolescents with depressive disorder

Next Previous
Trial Profile

A phase 3 clinical trial of duloxetine in children and adolescents with depressive disorder

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Jan 2019

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Eli Lilly; Shionogi

    • Most Recent Events

    • 26 Jan 2019 Last checked against ClinicalTrials.gov record.
    • 30 Nov 2017 Status changed from not yet recruiting to recruiting.
    • 21 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top